ArticleEuropean journal of medicinal chemistry2022

Development of sulfonamide-based NLRP3 inhibitors: Further modifications and optimization through structure-activity relationship studies.

Yiming Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.